Viva Biotech Holdings
Company Profile
Business description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact
735 Ziping Road
Pudong New District
Zhoupu Town
Shanghai201318
CHNT: +86 2160893288
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2,085
Stocks News & Analysis
stocks
PayPal earnings: Growth slows, new CEO appointed
stocks
Morningstar initiates on ASX income play
stocks
What Goodman’s upcoming earnings could reveal about data centre & AI growth
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,204.60 | 56.50 | 0.62% |
| CAC 40 | 8,254.25 | 74.75 | 0.91% |
| DAX 40 | 24,643.37 | 137.42 | -0.55% |
| Dow JONES (US) | 49,240.99 | 166.67 | -0.34% |
| FTSE 100 | 10,452.09 | 137.50 | 1.33% |
| HKSE | 26,847.32 | 12.55 | 0.05% |
| NASDAQ | 23,255.19 | 336.92 | -1.43% |
| Nikkei 225 | 54,293.36 | 427.30 | -0.78% |
| NZX 50 Index | 13,467.29 | 45.77 | 0.34% |
| S&P 500 | 6,917.81 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,927.80 | 75.50 | 0.85% |
| SSE Composite Index | 4,102.20 | 34.46 | 0.85% |